title: Concurrent chemoimmunotherapy: is it still the best option for the treatment of metastatic melanoma in patients with good performance status?
authors.affiliation: Clinic of Oncology, University Clinical Centre Nis, Nis, Serbia. ivicapejcic@gmail.com
authors.forename: I
authors.initials: I
authors.lastname: Pejcic
authors.forename: S
authors.initials: S
authors.lastname: Vrbic
authors.forename: S
authors.initials: S
authors.lastname: Filipovic
authors.forename: M
authors.initials: M
authors.lastname: Scekic
authors.forename: I
authors.initials: I
authors.lastname: Petkovic
authors.forename: Lj
authors.initials: Lj
authors.lastname: Pejcic